Spider toxin inhibits gating pore currents underlying periodic paralysis.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 29636418.
- Also identified by DOI 10.1073/pnas.1720185115 and PMC identifier 5924911.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Gating pore currents through the voltage-sensing domains (VSDs) of the skeletal muscle voltage-gated sodium channel Na<sub>V</sub>1.4 underlie hypokalemic periodic paralysis (HypoPP) type 2. Gating modifier toxins target ion channels by modifying the function of the VSDs. We tested the hypothesis that these toxins could function as blockers of the pathogenic gating pore currents. We report that a crab spider toxin Hm-3 from <i>Heriaeus melloteei</i> can inhibit gating pore currents due to mutations affecting the second arginine residue in the S4 helix of VSD-I that we have found in patients with HypoPP and describe here. NMR studies show that Hm-3 partitions into micelles through a hydrophobic cluster formed by aromatic residues and reveal complex formation with VSD-I through electrostatic and hydrophobic interactions with the S3b helix and the S3-S4 extracellular loop. Our data identify VSD-I as a specific binding site for neurotoxins on sodium channels. Gating modifier toxins may constitute useful hits for the treatment of HypoPP.
Medical subject headings
- Mutation, Missense
- NAV1.4 Voltage-Gated Sodium Channel
- Neurotoxins
- Paralysis, Hyperkalemic Periodic
- Protein Structure, Secondary
- Spider Venoms